Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
MERIDIAN BIOSCIENCE INC (VIVO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 11.3% stake in Meridian Bioscience Inc. |
| 02/09/2023 |
10-Q
| Quarterly Report for the period ended December 31, 2022 |
| 02/06/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/06/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/06/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/03/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/01/2023 |
8-K
| Quarterly results |
| 01/31/2023 |
4
| Williams Felicia (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC|
Txns:
| Disposed/sold 10,274 shares
@ $0
Disposed/sold 12,000 options to buy
@ $15.15, valued at
$181.8k
Disposed/sold 8,740 options to buy
@ $16.97, valued at
$148.3k
Disposed/sold 17,205 options to buy
@ $10.46, valued at
$180k
Disposed/sold 5,796 options to buy
@ $21.36, valued at
$123.8k
Disposed/sold 5,656 options to buy
@ $20.75, valued at
$117.4k
|
|
| 01/31/2023 |
4
| Sazdanoff Catherine (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC|
Txns:
| Disposed/sold 16,424 shares
@ $0
Disposed/sold 8,500 options to buy
@ $18.18, valued at
$154.5k
Disposed/sold 8,500 options to buy
@ $18.64, valued at
$158.4k
Disposed/sold 12,000 options to buy
@ $12.8, valued at
$153.6k
Disposed/sold 12,000 options to buy
@ $16.2, valued at
$194.4k
Disposed/sold 8,740 options to buy
@ $16.97, valued at
$148.3k
Disposed/sold 17,205 options to buy
@ $10.46, valued at
$180k
Disposed/sold 5,796 options to buy
@ $21.36, valued at
$123.8k
Disposed/sold 5,656 options to buy
@ $20.75, valued at
$117.4k
|
|
| 01/31/2023 |
4
| Rice John McCune Jr. (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC|
Txns:
| Disposed/sold 27,449 shares
@ $0
Disposed/sold 12,000 options to buy
@ $16.2, valued at
$194.4k
Disposed/sold 8,740 options to buy
@ $16.97, valued at
$148.3k
Disposed/sold 5,796 options to buy
@ $21.36, valued at
$123.8k
Disposed/sold 5,656 options to buy
@ $20.75, valued at
$117.4k
|
|
| 01/31/2023 |
4
| McIlwraith John (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC|
Txns:
| Disposed/sold 21,724 shares
@ $0
Disposed/sold 8,500 options to buy
@ $18.18, valued at
$154.5k
Disposed/sold 8,500 options to buy
@ $18.64, valued at
$158.4k
Disposed/sold 10,000 options to buy
@ $12.8, valued at
$128k
Disposed/sold 12,000 options to buy
@ $16.2, valued at
$194.4k
Disposed/sold 8,740 options to buy
@ $16.97, valued at
$148.3k
Disposed/sold 17,205 options to buy
@ $10.46, valued at
$180k
Disposed/sold 5,796 options to buy
@ $21.36, valued at
$123.8k
Disposed/sold 5,656 options to buy
@ $20.75, valued at
$117.4k
|
|
| 01/31/2023 |
4
| Ellingwood Dwight E (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC|
Txns:
| Disposed/sold 17,290 shares
@ $0
Disposed/sold 8,500 options to buy
@ $20.8, valued at
$176.8k
Disposed/sold 5,500 options to buy
@ $17.34, valued at
$95.4k
Disposed/sold 8,500 options to buy
@ $18.64, valued at
$158.4k
Disposed/sold 11,000 options to buy
@ $12.8, valued at
$140.8k
Disposed/sold 12,000 options to buy
@ $16.2, valued at
$194.4k
Disposed/sold 8,740 options to buy
@ $16.97, valued at
$148.3k
Disposed/sold 17,205 options to buy
@ $10.46, valued at
$180k
Disposed/sold 5,796 options to buy
@ $21.36, valued at
$123.8k
Disposed/sold 5,656 options to buy
@ $20.75, valued at
$117.4k
|
|
| 01/31/2023 |
4
| Bihl Anthony P III (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC|
Txns:
| Disposed/sold 15,408 shares
@ $0
Disposed/sold 4,595 options to buy
@ $23.5, valued at
$108k
Disposed/sold 5,796 options to buy
@ $21.36, valued at
$123.8k
Disposed/sold 5,656 options to buy
@ $20.75, valued at
$117.4k
|
|
| 01/31/2023 |
4
| Anderson James M. (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC|
Txns:
| Disposed/sold 28,224 shares
@ $0
Disposed/sold 5,000 shares
@ $0
Disposed/sold 8,500 options to buy
@ $25.83, valued at
$219.6k
Disposed/sold 8,500 options to buy
@ $17.34, valued at
$147.4k
Disposed/sold 8,500 options to buy
@ $18.64, valued at
$158.4k
Disposed/sold 12,000 options to buy
@ $12.8, valued at
$153.6k
Disposed/sold 12,000 options to buy
@ $16.2, valued at
$194.4k
Disposed/sold 8,740 options to buy
@ $16.97, valued at
$148.3k
Disposed/sold 17,205 options to buy
@ $10.46, valued at
$180k
Disposed/sold 5,796 options to buy
@ $21.36, valued at
$123.8k
Disposed/sold 5,656 options to buy
@ $20.75, valued at
$117.4k
|
|
| 01/31/2023 |
4
| Kenny John P. (CEO) has filed a Form 4 on MERIDIAN BIOSCIENCE INC|
Txns:
| Granted 47,060 shares
@ $0
Disposed/sold 267,651 shares
@ $0
Disposed/sold 66,039 options to buy
@ $10.1, valued at
$667k
Disposed/sold 83,535 options to buy
@ $18.48, valued at
$1.5M
Disposed/sold 82,940 options to buy
@ $18.88, valued at
$1.6M
|
|
| 01/31/2023 |
4
| Kitzmiller Andrew S. (Executive Vice President & CFO) has filed a Form 4 on MERIDIAN BIOSCIENCE INC|
Txns:
| Granted 7,945 shares
@ $0
Disposed/sold 19,473 shares
@ $0
Disposed/sold 5,000 options to buy
@ $24.74, valued at
$123.7k
|
|
| 01/31/2023 |
4
| WELTZIEN LOURDES (Executive VP, Life Science) has filed a Form 4 on MERIDIAN BIOSCIENCE INC|
Txns:
| Granted 7,945 shares
@ $0
Disposed/sold 86,045 shares
@ $0
Disposed/sold 10,000 options to buy
@ $19.66, valued at
$196.6k
Disposed/sold 2,500 options to buy
@ $14.3, valued at
$35.8k
Disposed/sold 12,107 options to buy
@ $18.48, valued at
$223.7k
Disposed/sold 11,669 options to buy
@ $18.88, valued at
$220.3k
|
|
|
|
|